[go: up one dir, main page]

WO2002072137A3 - Anaesthetic formulation comprising articaine - Google Patents

Anaesthetic formulation comprising articaine Download PDF

Info

Publication number
WO2002072137A3
WO2002072137A3 PCT/GB2002/001056 GB0201056W WO02072137A3 WO 2002072137 A3 WO2002072137 A3 WO 2002072137A3 GB 0201056 W GB0201056 W GB 0201056W WO 02072137 A3 WO02072137 A3 WO 02072137A3
Authority
WO
WIPO (PCT)
Prior art keywords
articaine
anaesthetic formulation
anaesthetic
formulation
peribulbar
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2002/001056
Other languages
French (fr)
Other versions
WO2002072137A2 (en
Inventor
Keith Gregory Allman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Royal Devon & Exeter Healthcare Nhs Trust
Royal Devon & Exeter Healthcar
Original Assignee
Royal Devon & Exeter Healthcare Nhs Trust
Royal Devon & Exeter Healthcar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Royal Devon & Exeter Healthcare Nhs Trust, Royal Devon & Exeter Healthcar filed Critical Royal Devon & Exeter Healthcare Nhs Trust
Priority to AU2002238736A priority Critical patent/AU2002238736A1/en
Publication of WO2002072137A2 publication Critical patent/WO2002072137A2/en
Publication of WO2002072137A3 publication Critical patent/WO2002072137A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An anaesthetic formulation for peribulbar anaesthesia incorporates articaine.
PCT/GB2002/001056 2001-03-10 2002-03-08 Anaesthetic formulation comprising articaine Ceased WO2002072137A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002238736A AU2002238736A1 (en) 2001-03-10 2002-03-08 Anaesthetic formulation comprising articaine

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0105944.3A GB0105944D0 (en) 2001-03-10 2001-03-10 Anaesthetic Formulation
GB0105944.3 2001-03-10

Publications (2)

Publication Number Publication Date
WO2002072137A2 WO2002072137A2 (en) 2002-09-19
WO2002072137A3 true WO2002072137A3 (en) 2002-11-21

Family

ID=9910402

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/001056 Ceased WO2002072137A2 (en) 2001-03-10 2002-03-08 Anaesthetic formulation comprising articaine

Country Status (3)

Country Link
AU (1) AU2002238736A1 (en)
GB (1) GB0105944D0 (en)
WO (1) WO2002072137A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2597155C2 (en) * 2014-09-24 2016-09-10 Общество с ограниченной ответственностью "Центр малоинвазивной лазерной медицины" (ООО "Центр МИЛМ") Method for block anaesthesia accompanying intranasal surgical correction

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075059A (en) * 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
WO2001045678A2 (en) * 1999-12-21 2001-06-28 Id Pharma Gmbh Medicament, a method for its production and the use thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6075059A (en) * 1999-02-24 2000-06-13 The Ohio State University Compositions for dental anesthesia
WO2001045678A2 (en) * 1999-12-21 2001-06-28 Id Pharma Gmbh Medicament, a method for its production and the use thereof

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
ALLMAN, K. G. ET AL: "Comparison of articaine and bupivacaine/lidocaine for single medial canthus peribulbar anesthesia", BRITISH JOURNAL OF ANAESTHESIA (2001), 87(4), 584-587, XP008007528 *
BARR, J. ET AL: "Effect of adrenaline and hyaluronidase on plasma concentrations of lignocaine and bupivacaine after peribulbar anesthesia", BRITISH JOURNAL OF ANAESTHESIA (1995), 75(6), 692-7, XP008007459 *
BOHLENDER T. ET AL: "PERIBULBARANASTHESIE TRANSKUTAN ODER TRANSKONJUNKTIVAL?.", OPHTHALMOLOGE, (1997) 94/5, 324-326, XP001100651 *
DEMPSEY, G. A. ET AL: "Hyaluronidase and peribulbar block", BRITISH JOURNAL OF ANAESTHESIA (1997), 78(6), 671-674, XP008007525 *
KALLIO, HELENA ET AL: "Hyaluronidase as an adjuvant in bupivacaine-lidocaine mixture for retrobulbar / peribulbar block", ANESTHESIA & ANALGESIA (BALTIMORE) (2000), 91(4), 934-937, XP008007526 *
KRAUSE M. ET AL: "Does warming of anesthetic, solutions improve analgesia and akinesia in retrobulbar anesthesia?.", OPHTHALMOLOGY, (1997) 104/3 (429-432)., XP008007514 *
SCHNEIDER G.: "[Experiences with carticain in anaesthesia prior to ophthalmic operation]. ERFAHRUNGEN MIT CARTICAIN BEI DER ANAESTHESIE VOR OPHTHALMOLOGISCHEN EINGRIFFEN.", BERICHTE DER DEUTSCHEN OPHTHALMOLOGISCHEN GESELLSCHAFT, (1981) VOL. 78/- (909-910). CODEN: DOPGAM, XP008007513 *
WEINDLER J. ET AL: "Low-dose oral clonidine as premedication before intraocular surgery in retrobulbar anesthesia.", EUROPEAN JOURNAL OF OPHTHALMOLOGY, (2000) 10/3 (248-256)., XP008007521 *
WOODWARD, D. K. ET AL: "Peribulbar anaesthesia with 1% ropivacaine and hyaluronidase 300 IU ml-1: comparison with 0.5% bupivacaine/2% lidocaine and hyaluronidase 50 IU ml-1", BRITISH JOURNAL OF ANAESTHESIA (2000), 85(4), 618-620, XP008007527 *

Also Published As

Publication number Publication date
AU2002238736A1 (en) 2002-09-24
WO2002072137A2 (en) 2002-09-19
GB0105944D0 (en) 2001-04-25

Similar Documents

Publication Publication Date Title
AU2002234476A1 (en) Medical aerosol formulations
EP1670472B8 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
AU2002342074A1 (en) Medical device for delivering patches
MXPA03006884A (en) Pharmaceutical formulation.
AU2002364508A1 (en) Open-celled substrates for drug delivery
AU2002257582A1 (en) Pharmaceutical formulation
AU2001258550A1 (en) Insulin formulation for inhalation
ZA200402729B (en) Pharmaceutical formulation comprising (R) -bicalutamide.
AU2002301057A1 (en) Humidified Gases Delivery Apparatus
AU2002342562A1 (en) Anesthetic device
WO2002072137A3 (en) Anaesthetic formulation comprising articaine
AU2002340440A1 (en) Foamable antimicrobial formulation
AU2002238748A1 (en) Pharmaceutical aerosol formulation
AU2002342739A1 (en) Diffuser for active ingredients
ZA200402731B (en) Pharmaceutical formulation.
AU2002318949A1 (en) Instrument treatment station
AU2002329433A1 (en) Formulation
AU2001248225A1 (en) Mosquito-repellent incense
AU2002301078B2 (en) An Inhaler
AU2002346818A1 (en) Insecticide composition
HK1066478A (en) Pharmaceutical formulation comprising (r)-bicalutamide
HK1067289A (en) Mobile patient monitor
AU2002360881A1 (en) Anesthesia syringe
AUPR826801A0 (en) Inhaling device
AUPR718201A0 (en) Polymer formulations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP